|
WO2021030553A1
|
|
Methods of treating cryptococcus infections
|
|
CN109689028A
|
|
The antifungal compound of the lipid volume encapsulating of Cryptococcus infections is delivered and treated for central nervous system
|
|
WO2017205550A1
|
|
Immunogenic cochleates and methods of use
|
|
US2018185308A1
|
|
Compositions and methods for treating inflammatory disease or conditions
|
|
US2018153807A1
|
|
Compositions and methods for treating mycobacteria infections and lung disease
|
|
AU2016226151A1
|
|
Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
|
|
MX2015001348A
|
|
Cochleates made with soy phosphatidylserine.
|
|
AU2012250568A1
|
|
Cochleate compositions and methods of making and using same
|
